Important pharmacy news and late-breaking industry information updated daily.

A new study published in Arthritis Care & Research found that it’s common for patients with gout to be discharged from the emergency department (ED) with a prescription for opioids.

U.S. District Court Judge Amit Mehta on Monday ruled the Trump administration overstepped its authority with a rule to force drug companies to include the price of their medicine in television advertisements.

Several states, including Virginia and Vermont, have laws mandating that clinicians coprescribe naloxone with opioids to high-risk patients. A new study published in JAMA Network Open suggests that these legal mandates are associated with substantial increases in naloxone dispensing.

President Trump on Friday said his administration is writing an executive order to require drug manufacturers to offer the United States government among the lowest prices in the world, in comments that were not immediately clear to many experts on the nation's health care system.

FDA on Wednesday granted accelerated approval to selinexor (Xpovio—Karyopharm Therapeutics) tablets in combination with the corticosteroid dexamethasone for the treatment of adult patients with relapsed refractory multiple myeloma (RRMM) who have received at least four prior therapies and whose disease is resistant to several other forms of t

Accurate estimation of glomerular filtration rates (GFR) in older patients is important to identify renal impairment and guide drug dosing. An analysis of four equations used in estimating GFR in patients aged 65 years and older showed that all four had similar diagnostic performances. These results, published in JAMA Internal Medicine, suggest that any of them can be used in older patients to estimate GFR.

Facebook and YouTube are being flooded with scientifically dubious and potentially harmful information about alternative cancer treatments, which sometimes gets viewed millions of times. The companies say they are taking steps to curb such accounts.

Now a fourth potential carcinogen is being linked to the popular blood pressure medication valsartan. FDA has been informed that a solvent called dimethylformamide (DMF) was discovered in valsartan made by several companies, including Novartis. DMF is classified by the World Health Organization as a probable carcinogen.

Twenty companies raised the list prices of more than 40 prescription drugs by an average of 13.1% on Monday, according to Rx Savings Solutions. On July 1 last year, 16 companies raised the list prices of dozens of drugs by an average 7.8%. Drug companies had typically raised list prices at the start of the year and again 6 months later.

Use of short-acting exenatide with and without basal insulin in noncritically ill hospitalized patients improved glycemic control and was well tolerated, according to data published in Diabetes Care.